Literature DB >> 17052448

Priapism: new concepts in the pathophysiology and new treatment strategies.

Trinity J Bivalacqua1, Arthur L Burnett.   

Abstract

Priapism is defined as prolonged and persistent erection of the penis without sexual stimulation. This is a poorly understood disease process, and we have little information on the etiology and pathophysiology of this erectile disorder. Two main types of priapism exist: low-flow (ischemic) and high-flow (nonischemic) priapism. When the physician first diagnoses which type of priapism exists, distinguishing the type of priapic event is paramount in order to choose the correct treatment options. Until recently, we had not sufficiently understood the pathogenesis of this erectile disorder and therefore, could not effectively manage its pathologic consequences of erectile tissue damage and erectile dysfunction. In this review, the proposed pathogenesis of ischemic priapism is reviewed, and a survey regarding novel treatment modalities is given.

Entities:  

Mesh:

Year:  2006        PMID: 17052448     DOI: 10.1007/s11934-006-0061-6

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  41 in total

1.  Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study.

Authors:  A B Adeyoju; A B K Olujohungbe; J Morris; A Yardumian; D Bareford; A Akenova; O Akinyanju; K Cinkotai; P H O'Reilly
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

Review 2.  Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease.

Authors:  Trinity J Bivalacqua; Mustafa F Usta; Hunter C Champion; Philip J Kadowitz; Wayne J G Hellstrom
Journal:  J Androl       Date:  2003 Nov-Dec

3.  Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.

Authors:  A I El-Sakka; H M Hassoba; R J Pillarisetty; R Dahiya; T F Lue
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

4.  Effect of pentoxifylline on veno-occlusive priapism-induced corporeal tissue lipid peroxidation in a rat model.

Authors:  Y Evliyaoğlu; L Kayrin; B Kaya
Journal:  Urol Res       Date:  1997

5.  Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.

Authors:  K Chitaley; C J Wingard; R Clinton Webb; H Branam; V S Stopper; R W Lewis; T M Mills
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

6.  Hypoxia potentiates transforming growth factor-beta expression of hepatocyte during the cirrhotic condition in rat liver.

Authors:  Won-Ii Jeong; Sun-Hee Do; Hae-Sun Yun; Byoung-Joon Song; Seong-Jin Kim; Wie-Jong Kwak; Sung-Eun Yoo; Ho-Yong Park; Kyu-Shik Jeong
Journal:  Liver Int       Date:  2004-12       Impact factor: 5.828

Review 7.  Priapism pathophysiology: clues to prevention.

Authors:  A L Burnett
Journal:  Int J Impot Res       Date:  2003-10       Impact factor: 2.896

8.  The incidence and management of priapism in Western Australia: a 16 year audit.

Authors:  C M Earle; B G A Stuckey; H L Ching; Z S Wisniewski
Journal:  Int J Impot Res       Date:  2003-08       Impact factor: 2.896

9.  Pharmacologic erection: time-dependent changes in the corporal environment.

Authors:  G A Broderick; R Harkaway
Journal:  Int J Impot Res       Date:  1994-03       Impact factor: 2.896

10.  Expression of TGF-beta-1 mRNA and ultrastructural alterations in pharmacologically induced prolonged penile erection in a canine model.

Authors:  M Ul-Hasan; A I El-Sakka; C Lee; T S Yen; R Dahiya; T F Lue
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

View more
  17 in total

1.  Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.

Authors:  Arthur L Burnett; Uzoma A Anele; Irene N Trueheart; John J Strouse; James F Casella
Journal:  Am J Med       Date:  2014-03-25       Impact factor: 4.965

2.  Intractable acute ischaemic priapism occurring secondary to newly commenced olanzapine.

Authors:  Matthew Farag; Jeremy Goad; Catherine Temelcos
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 3.  Medical management of ischemic stuttering priapism: a contemporary review of the literature.

Authors:  Helen R Levey; Omer Kutlu; Trinity J Bivalacqua
Journal:  Asian J Androl       Date:  2011-11-07       Impact factor: 3.285

Review 4.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

Review 5.  Treatments for priapism in boys and men with sickle cell disease.

Authors:  Francis I Chinegwundoh; Sherie Smith; Kofi A Anie
Journal:  Cochrane Database Syst Rev       Date:  2017-09-19

6.  Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-01-09       Impact factor: 3.802

Review 7.  Treatment dilemmas: strategies for priapism, chronic leg ulcer disease, and pulmonary hypertension in sickle cell disease.

Authors:  Roberta C G Azbell; Payal Chandarana Desai
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 8.  A pathophysiology-based approach to the management of early priapism.

Authors:  Jason R Kovac; Siu K Mak; Maurice M Garcia; Tom F Lue
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

9.  Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.

Authors:  Trinity J Bivalacqua; Biljana Musicki; Lewis L Hsu; Mark T Gladwin; Arthur L Burnett; Hunter C Champion
Journal:  J Sex Med       Date:  2009-06-11       Impact factor: 3.802

10.  Priapism in antipsychotic drug use: a rare but important side effect.

Authors:  Igne Sinkeviciute; Rune A Kroken; Erik Johnsen
Journal:  Case Rep Psychiatry       Date:  2012-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.